Upcoming verified earnings release
Inhibikase Therapeutics Q4 2026 Earnings Preview
Direct answer
Inhibikase Therapeutics is scheduled to report Q4 2026 earnings on March 24, 2027.
After the US market closes. The available EPS estimate is -0.1167.
This page will keep the same address and add the reported result when the verified source provides it.
Verified earnings source
Get free Inhibikase Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- March 24, 2027
- Reported timing
- After the US market closes
- EPS estimate
- -0.1167
- Reported EPS
- Not provided
Explore related company data
Read the frequently asked questions.
When is Inhibikase Therapeutics scheduled to report Q4 2026 earnings?
Inhibikase Therapeutics is scheduled to report on March 24, 2027. The reported timing is after the us market closes.
What is the available EPS estimate for Inhibikase Therapeutics?
The verified record provides an EPS estimate of -0.1167.
Has Inhibikase Therapeutics reported the Q4 2026 result?
A reported result has not yet been verified. This same page will show the result after verification.
Which source supports this Inhibikase Therapeutics earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.